XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
Stockholders' Equity and Earnings per Common Share
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
Stockholders' Equity and Earnings per Common Share

Note 7 - Stockholders’ Equity and Earnings per Common Share

Stockholders’ Equity

Holders of our common stock are entitled to one vote for each share.

On March 2, 2021, we entered into a distribution agreement with J.P. Morgan Securities LLC, Barclays Capital Inc., B. Riley Securities, Inc., JMP Securities LLC and Raymond James & Associates, Inc. as sales agents, to sell shares of our common stock having an aggregate gross sales price of up to $200,000,000, from time to time, through an “at-the-market” equity offering program (the “ATM Program”). We have no obligation to sell any shares under the ATM Program, and sold no shares under the ATM Program during the three months ended March 31, 2022 and 2021.

As of March 31, 2022 and December 31, 2021 there were 41.7 million Public Warrants outstanding and 5.2 million Private Placement Warrants outstanding. In the aggregate, we have outstanding warrants to purchase approximately 15.6 million shares of common stock at a price of $11.50 per whole share. Settlement of outstanding warrants will be in shares of our common stock, unless we elect (solely in our discretion) to settle warrants we have called for redemption in cash, and subject to customary adjustment in the event of business combinations and certain tender offers.

The liability for the Private Placement Warrants was $1.8 million as of March 31, 2022 and is included in accounts payable and accrued liabilities in the condensed consolidated balance sheet.

 

Earnings per Common Share

The table below presents the computation of basic and diluted net income per share of common stock for the periods presented:

 

 

 

Three Months Ended

 

(dollars in thousands, except share and per share data):

 

March 31, 2022

 

 

March 31, 2021

 

Net income

 

$

18,074

 

 

$

20,381

 

Basic weighted-average shares of common stock outstanding

 

 

132,769,876

 

 

 

132,550,227

 

Dilutive effect of share-based compensation – unvested restricted stock units

 

 

66,895

 

 

 

128,585

 

Diluted weighted-average shares of common stock outstanding

 

 

132,836,771

 

 

 

132,678,812

 

Basic earnings per share

 

$

0.14

 

 

$

0.15

 

Diluted earnings per share

 

$

0.14

 

 

$

0.15

 

For the periods presented, the following common stock equivalents were excluded from the calculations of diluted earnings per share because their effect would have been anti-dilutive:

 

 

 

Three Months Ended

 

 

 

March 31, 2022

 

 

March 31, 2021

 

Weighted-average restricted stock units outstanding

 

 

427,174

 

 

 

249,962

 

Unexercised Public Warrants and Private Placement Warrants

 

 

15,604,279

 

 

 

15,604,304

 

Total stock equivalents excluded

 

 

16,031,453

 

 

 

15,854,266